Conclusion. Ceftobiprole is a novel, broad-spectrum, parenteral cephalosporin undergoing Phase III clinical trials. Its broad spectrum of activity makes it a candidate for monotherapy of cSSSIs ...

Christine M. Slover, PharmD, Infectious Diseases Fellow, Keith A. Rodvold, PharmD and Larry H. Danziger, PharmD, Professor, Department of Pharmacy Practice ...

You want to expand your cat roster, but you also want to put together a team made of some of the strongest, most interesting cats in The Battle Cats? Then look no further, because our Battle Cats tier ...

Watch the latest news from across the country on Spectrum News+.

After hours: December 10 at 4:05:03 PM EST ...